Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Net Loss per Share | ||
Antidilutive securities excluded from common stock (in shares) | 5,546,555 | 3,573,626 |
Unvested restricted common stock | ||
Net Loss per Share | ||
Antidilutive securities excluded from common stock (in shares) | 463,964 | 0 |
Unvested shares from early exercises | ||
Net Loss per Share | ||
Antidilutive securities excluded from common stock (in shares) | 53,741 | 111,756 |
Stock Options | ||
Net Loss per Share | ||
Antidilutive securities excluded from common stock (in shares) | 5,028,850 | 3,461,870 |